HUYA Bioscience International announced Wednesday an expansion of its senior management team with the appointment of Yoshiki Shimamura as vice president for Japan operations.
Carlsbad-based Eolas Therapeutics Inc. announced Wednesday that is has entered into a worldwide license and partnership agreement with AstraZeneca in a deal potentially worth $145 million.
Sorrento Therapeutics Inc.’s stock surged almost 20 percent last week, continuing a trend of strong performance, as shares have gained 37.5 percent in the second quarter.
La Jolla Pharmaceutical Co.’s stock surged by more than 17 percent last week, spurred by director Kevin Tang’s purchase of 53,836 shares last Tuesday.
Celladon Corp. announced that it will suspend all research and development activities.
Encore Medical, a subsidiary of Vista-based medical device firm DJO Global, has entered into an agreement with Zimmer Holdings Inc. to purchase products to help it invest in the implant business.
Palomar Health’s Board of Directors voted June 24 to close Palomar Health Downtown Hospital in Escondido.
La Jolla-based Avalon Ventures led a $17 million Series A round for Ankasa Regenerative Therapeutics, handing over $8.5 million of the funding to the upstart biotech working on new tech for reactivating stem cells and tissue regeneration.
BIOTECH: Current Scanners Cumbersome Costly and Overbooked
Local startup JAS Neuro Imaging has forged a partnership with Maryland-based Brain Biosciences to bring breakthrough brain technology directly to the doctor’s office.
The Sanford-Burnham Medical Research Institute has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.